Financials

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5067
DCOY
Decoy Therapeutics Inc. - Common Stock
2.91 USD-2.02%-9.06%-26.70%+259.79%1.91 M USD
5229
AZN
AstraZeneca PLC - American Depositary Shares
162.70 USD-1.10%-1.14%-6.55%+104.42%0 USD
7289
SCLXW
Scilex Holding Company - Warrant
0.1579 USD0.00%+20.53%-16.89%-65.86%46.12 M USD
7359
MDCXW
Medicus Pharma Ltd. - Warrant
0.3302 USD0.00%0.00%-33.95%-48.85%16.43 M USD

Frequently asked questions about Grifois, S.A.

What is the Grifois, S.A. stock price today?

The current price of Grifois, S.A. (GRFS) is 7.69. Over the past 24 hours, the stock has changed by -1.66%. Follow the GRFS chart for real-time price dynamics.

What is the stock ticker of Grifois, S.A.?

Grifois, S.A. trades under the ticker GRFS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Grifois, S.A. stock going up?

GRFS has changed by -3.88% over the last week, -7.01% over the last month, and -22.01% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Grifois, S.A.?

Grifois, S.A. currently has a market capitalization of 0. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Grifois, S.A. release financial reports?

Yes. You can track Grifois, S.A. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

How many employees does Grifois, S.A. have?

As of the latest available data, Grifois, S.A. has 25.25 K employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Grifois, S.A. stock?

You can buy Grifois, S.A. (GRFS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Grifois, S.A. stock?

Investing in Grifois, S.A. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GRFS chart and related analysis on metatrader.com as part of your research.

Grifols, S.A. - American Depositary Shares

Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30. Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care.

News